Jump to content
Powered by BIOPRO BW
Show menu
  • Dossier Advanced therapy medicinal products

    Novel gene and cell therapies are associated with high expectations in the treatment of incurable and hereditary diseases. Among them, CAR-T cell therapies have emerged as a major hope in cancer treatment.
    © BIOPRO Baden-Württemberg GmbH

  • Contact Stay in touch

    Would you like continue receiving e-mail notifications about our activities, up-to-date information, events, opportunities for cooperation and general industry information? Register here to stay informed about current issues.
    © denisismagilov / Adobe Stock

  • Industry report The healthcare industry in Baden-Württemberg

    BIOPRO's new report entitled "Healthcare Industry 2020: Facts and Figures for Baden-Württemberg" illustrates key figures like num the number of companies, number of employees and taxable turnover for the biotechnology, medical technology and pharmaceutical industry.
    © MR.LIGHTMAN / Adobe Stock

Call for Expression of Interest until 31st of July, 2025

PRECISEU is an EU project aimed at accelerating the development of personalized healthcare, particularly in the field of novel therapies. Within this framework, four Joint Interregional Projects will officially launch in 2026 and run for three years. These projects offer opportunities for mentoring and individual support, matchmaking for the formation of project consortia, Europe-wide collaboration, as well as preparation for the PRECISEU funding call. Currently, the call for Expressions of Interest (EoI) is open — a non-binding invitation for interested parties to participate with their project ideas and products in order to contribute to the Joint International Projects. The application deadline is July 31st, 2025.

Latest news

  • AI-supported image recognition accelerates identification of zebrafish mutants - 16/07/2025

    In complex organisms, embryonic development is tightly regulated by intricate signalling pathways. When these pathways are disrupted, they can lead to characteristic developmental defects that are not easy to detect with the naked eye. Developmental biologist Prof. Dr. Patrick Müller from the University of Konstanz has developed EmbryoNet, an AI-powered software tool that uses image analysis to reliably identify such developmental disorders.

  • Press release - 15/07/2025

    With its Proof of Concept grants, the European Research Council (ERC) supports scientists in further developing the economic potential of their research results. Two scientists from the German Cancer Research Center (DKFZ) have now received this coveted funding for the second time.

  • Press release - 14/07/2025

    The protein SNAP-tag is a powerful tool for labeling proteins with synthetic fluorophores for bioimaging. Scientists at the Max Planck Institute for Medical Research in Heidelberg have engineered a much improved version named SNAP-tag2 as well as optimized substrates for faster labeling in live cells.

  • Press release - 11/07/2025

    An international research team has deciphered a mechanism of evolutionary arms race in human cells. The findings provide insights into how mobile elements in DNA hijack cellular functions – and how cells can defend themselves against this in order to prevent conditions such as tumour formation or chronic inflammation.

Upcoming events

Website address: https://www.gesundheitsindustrie-bw.de/en